SuCZee-D3
(Vitamin C with Zinc + D3 Chewable Tablets)
A healthy immune system protects us by defeating harmful foreign organisms that enter our body. For good health, the body’s immune system needs good and regular nourishment. Suczee-D3 is a unique supplement that is a combination of Vitamin C with Zinc + D3 to Supports the Immune System. Vitamin C is highly effective as an antioxidant & free radical scavenger. Zinc is an essential mineral for our body. It is best obtained from diet & supplements. Zinc supports brain health, cognitive & vitality performance. Vitamin D is one of the most important nutrients in our body. It is crucial in calcium absorption, blood-calcium balance and bone density regulation. It is responsible for the smooth functioning of more than 400 body functions.
Suczee-D3 is a powerful blend of immunity-boosting ingredients like 500 mg Vitamin C, 1000IU Vitamin D3, 27.5 mg Zinc (highest composition than most of the other products available in the market) which helps boost immune activity and maintain a powerful immune response. The tangy orange flavor enhances the taste of the Tablet.
- Sugar free
- Tangy Orange Flavor
- Diabetic friendly
- Result oriented formula
- Most economical combination with Vitamin C, Zinc &D3
- Produced under GMP & ISO 22000 standards
- Testedusing stringent protocols, process and guidelines following GLP
- We deliver value and quality which is equivalent to International standards.
Additional features of Chewable Tablets:
High Bioavailability, Sublingual administration
Gets absorbed into your system directly and quickly, without passing through stomach acids.
Good for those having trouble in swallowing medication
Benefits of suCZee-D3:
– Immunity Booster
– Infection management
– Arthritis management
– Osteoporosis management
– Cancer management
– Dental Health management
– Cardiac Health management
– Memory Booster
– Depression management
– Neuro Health management
– Diabetes management
– Healthy Skin
– Supports Bone Health
-Antioxidant support
Reviews
There are no reviews yet.